Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
Tomohiro Iida,1 Keirei Ishii2 1Department of Ophthalmology, Tokyo Women’s Medical University, Tokyo, 2Health Economics and Outcomes Research, Bayer Yakuhin Ltd., Osaka, Japan Purpose: The purpose of this study was to monitor anti-vascular endothelial growth factor (anti-VEGF) tr...
Enregistré dans:
Auteurs principaux: | Iida T, Ishii K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ed93e2d55e3748ca8d0f4ada973f89e0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
par: Varano M, et autres
Publié: (2016) -
Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
par: Amoaku W, et autres
Publié: (2018) -
Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degeneration
par: Taipale C, et autres
Publié: (2018) -
Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
par: Garweg JG
Publié: (2019) -
Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration
par: Bek T, et autres
Publié: (2018)